Back to Search Start Over

A novel treatment strategy for preterm birth: Intra-vaginal progesterone-loaded fibrous patches

Authors :
Muhammet Emin Cam
Francis Brako
Mehmet S. Eroglu
Ozan Ozkan
Hussain Alenezi
Hilal Turkoglu Sasmazel
Ayse Nur Hazar-Yavuz
Oguzhan Gunduz
Mohan Edirisinghe
Jubair Ahmed
Sumeyye Cesur
Guogang Ren
Levent Kabasakal
Cam, Muhammet Emin
Hazar-Yavuz, Ayse Nur
Cesur, Sumeyye
Ozkan, Ozan
Alenezi, Hussain
Sasmazel, Hilal Turkoglu
Eroglu, Mehmet Sayip
Brako, Francis
Ahmed, Jubair
Kabasakal, Levent
Ren, Guogang
Gunduz, Oguzhan
Edirisinghe, Mohan
Source :
International Journal of Pharmaceutics. 588:119782
Publication Year :
2020
Publisher :
Elsevier BV, 2020.

Abstract

Progesterone-loaded poly(lactic) acid fibrous polymeric patches were produced using electrospinning and pressurized gyration for intra-vaginal application to prevent preterm birth. The patches were intravaginally inserted into rats in the final week of their pregnancy, equivalent to the third trimester of human pregnancy. Maintenance tocolysis with progesterone-loaded patches was elucidated by recording the contractile response of uterine smooth muscle to noradrenaline in pregnant rats. Both progesterone-loaded patches indicated similar results from release and thermal studies, however, patches obtained by electrospinning had smaller average diameters and more uniform dispersion compared to pressurized gyration. Patches obtained by pressurized gyration had better results in production yield and tensile strength than electrospinning; thereby pressurized gyration is better suited for scaled-up production. The patches did not affect cell attachment, viability, and proliferation on Vero cells negatively. Consequently, progesterone-loaded patches are a novel and successful treatment strategy for preventing preterm birth.

Details

ISSN :
03785173
Volume :
588
Database :
OpenAIRE
Journal :
International Journal of Pharmaceutics
Accession number :
edsair.doi.dedup.....03c13c2abea12b50de1a6568fe7c1fc5
Full Text :
https://doi.org/10.1016/j.ijpharm.2020.119782